Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.25 is in line with its 5-year average of 3.48, near the low end of its 5-year range (0.61–20.61).
As of the fiscal period ended Tuesday, June 30, 2026. 47.02% above its 12-month average of 2.21.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.25.
CURRENT RATIO
3.25
CURRENT RATIO AVG TTM
2.21
CURRENT RATIO AVG 3Y
3.33
CURRENT RATIO AVG 5Y
3.48
CURRENT RATIO AVG 10Y
3.05
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+47.02%
CURRENT VS 3Y AVG
-2.29%
CURRENT VS 5Y AVG
-6.50%
CURRENT VS 10Y AVG
+6.38%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-13.36%
vs the sector median at left
Market Cap
$106.96M
Current Ratio
0.81
TTM Avg
0.51
3Y Avg
0.77
5Y Avg
1.23
Market Cap
$106.98M
Current Ratio
0.96
TTM Avg
1.08
3Y Avg
1.26
5Y Avg
1.56
Market Cap
$107.09M
Current Ratio
5.71
TTM Avg
10.50
3Y Avg
6.63
5Y Avg
5.88
Market Cap
$107.17M
Current Ratio
5.68
TTM Avg
5.13
3Y Avg
4.85
5Y Avg
5.20
Market Cap
$109.14M
Current Ratio
2.00
TTM Avg
1.45
3Y Avg
1.62
5Y Avg
1.71
Market Cap
$104.68M
Current Ratio
13.53
TTM Avg
12.93
3Y Avg
9.36
5Y Avg
9.36
Market Cap
$104.26M
Current Ratio
1.86
TTM Avg
1.97
3Y Avg
2.28
5Y Avg
2.24
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vivani Medical, Inc. (VANI) | $106.93M | 3.25 | 2.21 | 3.33 | 3.48 |
| Outlook Therapeutics, Inc. (OTLK)vs › | $106.96M | 0.81 | 0.51 | 0.77 | 1.23 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | 0.96 | 1.08 | 1.26 | 1.56 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.09M | 5.71 | 10.50 | 6.63 | 5.88 |
| Apyx Medical Corporation (APYX)vs › | $107.17M | 5.68 | 5.13 | 4.85 | 5.20 |
| Immunic, Inc. (IMUX)vs › | $106.52M | 5.05 | 1.26 | 3.56 | 6.57 |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.14M | 2.00 | 1.45 | 1.62 | 1.71 |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | 13.53 | 12.93 | 9.36 | 9.36 |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | 1.86 | 1.97 | 2.28 | 2.24 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.30M | 12.63 | 12.83 | 15.22 | 15.22 |
Current Ratio
3.25
Quick Ratio
3.25
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.25 |
| 2026-03-31 | 3.18 |
| 2025-12-31 | 2.71 |
| 2025-09-30 | 0.61 |
| 2025-06-30 | 1.30 |
| 2025-03-31 | 2.40 |
| 2024-12-31 | 3.41 |
| 2024-09-30 | 3.41 |
| 2024-06-30 | 4.55 |
| 2024-03-31 | 5.13 |
| 2023-12-31 | 4.03 |
| 2023-09-30 | 4.13 |
| 2023-06-30 | 5.11 |
| 2023-03-31 | 6.94 |
| 2022-12-31 | 6.97 |
| 2022-09-30 | 9.69 |
| 2022-06-30 | 1.35 |
| 2022-03-31 | 2.88 |
| 2021-12-31 | 1.18 |
| 2021-09-30 | 18.68 |
| 2021-06-30 | 20.61 |
| 2021-03-31 | 3.98 |
| 2020-12-31 | 0.83 |
| 2020-09-30 | 1.11 |
| 2020-06-30 | 1.68 |
| 2020-03-31 | 0.70 |
| 2019-12-31 | 1.88 |
| 2019-09-30 | 2.83 |
| 2019-06-30 | 3.58 |
| 2019-03-31 | 4.71 |
| 2018-12-31 | 1.27 |
| 2018-09-30 | 1.37 |
| 2018-06-30 | 1.75 |
| 2018-03-31 | 1.32 |
| 2017-12-31 | 1.99 |
| 2017-09-30 | 2.90 |
| 2017-06-30 | 4.17 |
| 2017-03-31 | 4.97 |
| 2016-12-31 | 2.70 |
| 2016-09-30 | 4.36 |
| 2016-06-30 | 5.40 |
| 2016-03-31 | 3.18 |
| 2015-12-31 | 3.35 |
| 2015-09-30 | 3.63 |
| 2015-06-30 | 4.04 |
| 2015-03-31 | 4.27 |
| 2014-12-31 | 4.97 |
| 2014-09-30 | 2.13 |
| 2014-06-30 | 3.27 |
| 2014-03-31 | 3.03 |
| 2013-12-31 | 4.39 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
